Inhaled Corticosteroids for Outpatients with Covid-19: A Meta-Analysis
2021; Cold Spring Harbor Laboratory; Linguagem: Inglês
10.1101/2021.11.04.21265945
AutoresTodd C. Lee, Émilie Bortolussi‐Courval, Sara Belga, Nick Daneman, Adrienne K. Chan, Ryan Hanula, Nicole Ezer, Emily G. McDonald,
Tópico(s)Respiratory Support and Mechanisms
ResumoAbstract The role of inhaled corticosteroids for outpatient COVID-19 is evolving. We meta-analyzed reported clinical trials and estimated probability of any effect and number needed to treat of 50 or 20 for symptom resolution by day 14 [100%, 99.8%, 93.1%] and hospitalization [89.3%, 72.9%, 26.7%] respectively.
Referência(s)